Blue Jet Healthcare Quarterly Results for Trading Insights
BLUEJET • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹136 Cr
QMarch 2021
Blue Jet Healthcare Quarterly Results Key Highlights
- Revenue of ₹508 Cr in March 2021 (+0.0% vs March 2021, -6.6% vs March 2020)
- Net Profit of ₹136 Cr in March 2021 (+0.0% vs March 2021, -6.2% vs March 2020)
- EBITDA of ₹215 Cr in March 2021 (+0.0% vs March 2021)
- Operating Margin of 41.0% in March 2021 (+0.0pp vs March 2021)
- Earnings Per Share of ₹1396.27 in March 2021 (+0.0% vs March 2021)
Blue Jet Healthcare Quarterly Results Analysis
| Metric | 2026 | March 2021 | March 2020 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 508 | 544 | - | - |
| Net Profit (₹ Cr) | 0 | 136 | 145 | - | - |
| EBITDA (₹ Cr) | 0 | 215 | 220 | - | - |
| EPS (₹) | 0.00 | 1396.27 | 1462.60 | - | - |
| Operating Margin (%) | 0.0% | 41.0% | 40.0% | - | - |
Blue Jet Healthcare Share Price Trend Around Quarterly Results
Visualize Blue Jet Healthcare's 1-year price movement across quarterly results — ideal for logging trades in Blue Jet Healthcare share price
chart using Tickjournal. All values in ₹.
Related Pages for Blue Jet Healthcare
Additional stock information and data for BLUEJET
Revenue Trend (₹ Cr)
March 2020
544
March 2021
508
2026
0
Net Profit Trend (₹ Cr)
March 2020
145
March 2021
136
2026
0
Operating Margin Trend (%)
March 2020
40.0%
March 2021
41.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Blue Jet Healthcare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1711.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6386.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4056.7 | 3,219 | 591 | +11.3% | - | 18.4% | 231.3 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1349.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1270.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores